About the journal
The Journal of Liquid Biopsy is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,080 USD. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2950-1954
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,080 USD
- Articles in DOAJ
- 251
- Declared review time
- 7 weeks
- Declared peer-review model
- double_blind
Index listings
- DOAJ · 2024-08-22
- Indexing
- DOAJ
- APC
- 2,080 USD
- Declared review time (DOAJ)
- 7 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
251
Most recent article
last month
Average review time (journal-declared via DOAJ)
7weeks
Works in OpenAlex
429
Last recorded publication year
2026
h-index
17
i10-index
34
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2024-08-22
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 47%
- ORCID iDs in current deposits
- 36%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918957761506676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Extracellular vesicles in disease
- Extracellular vesicles in disease
Show all subjects (50)
- Molecular Biology Techniques and Applications
- Molecular Biology Techniques and Applications
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Single-cell and spatial transcriptomics
- Lung Cancer Research Studies
- Single-cell and spatial transcriptomics
- Lung Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Lung Cancer Diagnosis and Treatment
- RNA modifications and cancer
- RNA modifications and cancer
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Epigenetics and DNA Methylation
- Renal cell carcinoma treatment
- Genomic variations and chromosomal abnormalities
- Epigenetics and DNA Methylation
- Renal cell carcinoma treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
- Ferroptosis and cancer prognosis
- Immunotherapy and Immune Responses
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Advanced biosensing and bioanalysis techniques
- Pancreatic and Hepatic Oncology Research
- Immunotherapy and Immune Responses
- Genomic variations and chromosomal abnormalities
- Advanced biosensing and bioanalysis techniques
- Ferroptosis and cancer prognosis
- PARP inhibition in cancer therapy
Keywords (DOAJ)
- liquid biopsy
- circulating tumor cells
- circulating tumor dna
- biomarkers
- molecular targeted therapy
- molecular diagnostic techniques
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ